ENPICOM introduces a powerful liability prediction solution to de-risk antibody development
The IGX Platform empowers researchers to accurately predict exposed liabilities for thousands of sequences at the same time using high-throughput structural modeling Caption:The IGX Platform to select better antibodies. To download image, please click here. ‘s-Hertogenbosch, The Netherlands – September 7, 2021 – Life Science Newswire – ENPICOM, an innovative bioinformatics software company, announced today at the Biologics UK conference new IGX... Read more